Pancreatic tumors and their surgical resection are associated with significant morbidity and mortality, and the biomarkers currently used for these conditions have limited sensitivity and specificity. Because calprotectin and calgranulin C serum levels have been demonstrated to be potential biomarkers of certain cancers and complications of major surgery, the levels of both proteins were tested in the current study in patients with benign and malignant pancreatic tumors that were surgically removed. The baseline serum levels and kinetics of calprotectin and calgranulin C during the 7-day postoperative period were evaluated with immunoassays in 98 adult patients who underwent pancreatic surgery. The baseline serum levels of calprotectin and calgranulin C in patients with malignant (n = 84) and benign tumors (n = 14) were significantly higher (p < 0.01) when compared to those in the healthy controls (n = 26). The serum levels of both proteins were also significantly (p < 0.05) higher in patients with benign tumors than in those with malignant tumors. After surgery, the serum levels of calprotectin and calgranulin C were significantly (p < 0.01) higher than their baseline values, and this elevation persisted throughout the seven days of the follow-up period. Interestingly, starting on day 1 of the postoperative period, the serum levels of both proteins were significantly (p < 0.05) higher in the 37 patients who developed postoperative pancreatic fistulas (POPFs) than in the patients who had uneventful recoveries (n = 61). Moreover, the serum levels of calprotectin and calgranulin C demonstrated a significant predictive value for the development of POPF; the predictive values of these two proteins were better than those of the serum level of C-reactive protein and the white blood cell count. Taken together, the results of this study suggest that calprotectin and calgranulin C serum levels are potential biomarkers for pancreatic tumors, surgical injury to the pancreatic tissue and the development of POPFs.

Department of Anesthesiology and Intensive Care Medicine University Hospital of Ostrava 17 Listopadu 1790 5 708 52 Ostrava Poruba Czech Republic

Department of Clinical Biochemistry Military University Hospital Prague 169 02 Praha 6 Czech Republic

Department of Clinical Microbiology Military University Hospital Prague 169 02 Praha 6 Czech Republic

Department of Infectious Diseases 1st Faculty of Medicine Charles University and Military University Hospital Prague 169 02 Praha 6 Czech Republic

Department of Surgery 2nd Faculty of Medicine Charles University and Military University Hospital Prague 169 02 Praha 6 Czech Republic

Zobrazit více v PubMed

Chan J. K., Roth J., Oppenheim J. J., et al. Alarmins: awaiting a clinical response. Journal of Clinical Investigation. 2012;122(8):2711–2719. doi: 10.1172/JCI62423. PubMed DOI PMC

Joly P., Marshall J. C., Tessier P. A., et al. S100A8/A9 and sRAGE kinetic after polytrauma; an explorative observational study. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine. 2017;25(1):p. 114. doi: 10.1186/s13049-017-0455-0. PubMed DOI PMC

Maca J., Holub M., Bursa F., et al. Alarmins as biomarkers of gastrointestinal surgical injury - a pilot study. APMIS. 2018;126(2):152–159. doi: 10.1111/apm.12798. PubMed DOI

Rau M., Schiller M., Krienke S., Heyder P., Lorenz H., Blank N. Clinical manifestations but not cytokine profiles differentiate adult-onset Still’s disease and sepsis. Journal of Rheumatology. 2010;37(11):2369–2376. doi: 10.3899/jrheum.100247. PubMed DOI

Ingels C., Derese I., Wouters P. J., Van den Berghe G., Vanhorebeek I. Soluble RAGE and the RAGE ligands HMGB1 and S100A12 in critical illness: impact of glycemic control with insulin and relation with clinical outcome. Shock. 2015;43(2):109–116. doi: 10.1097/SHK.0000000000000278. PubMed DOI

Hurnakova J., Hulejova H., Zavada J., et al. Serum calprotectin may reflect inflammatory activity in patients with active rheumatoid arthritis despite normal to low C-reactive protein. Clinical Rheumatology. 2018;37(8):2055–2062. doi: 10.1007/s10067-018-4091-5. PubMed DOI

Foell D., Wittkowski H., Hammerschmidt I., et al. Monitoring neutrophil activation in juvenile rheumatoid arthritis by S100A12 serum concentrations. Arthritis & Rheumatism. 2004;50(4):1286–1295. doi: 10.1002/art.20125. PubMed DOI

Topuz M. F., Binnetoglu A., Yumusakhuylu A. C., Sarı M., Baglam T., Gerin F. Circulating calprotectin as a biomarker of laryngeal carcinoma. European Archives of Oto-Rhino-Laryngology. 2017;274(6):2499–2504. doi: 10.1007/s00405-017-4480-4. PubMed DOI

Chen K. T., Kim P. D., Jones K. A., et al. Potential prognostic biomarkers of pancreatic cancer. Pancreas. 2014;43(1):22–27. doi: 10.1097/MPA.0b013e3182a6867e. PubMed DOI PMC

Hidalgo M. Pancreatic cancer. New England Journal of Medicine. 2010;362(17):1605–1617. doi: 10.1056/NEJMra0901557. PubMed DOI

Büchler M. W., Wagner M., Schmied B. M., Uhl W., Friess H., Z'graggen K. Changes in morbidity after pancreatic resection. Toward the end of completion pancreatectomy. Archives of Surgery. 2003;138(12):1310–1314. doi: 10.1001/archsurg.138.12.1310. PubMed DOI

Greenblatt D. Y., Kelly K. J., Rajamanickam V., et al. Preoperative factors predict perioperative morbidity and mortality after pancreaticoduodenectomy. Annals of Surgical Oncology. 2011;18(8):2126–2135. doi: 10.1245/s10434-011-1594-6. PubMed DOI

Máca J., Burša F., Ševčík P., Sklienka P., Burda M., Holub M. Alarmins and clinical outcomes after major abdominal surgery-a prospective study. Journal of Investigative Surgery. 2017;30(3):152–161. doi: 10.1080/08941939.2016.1231855. PubMed DOI

Bassi C., Marchegiani G., Dervenis C., et al. The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 years after. Surgery. 2017;161(3):584–591. doi: 10.1016/j.surg.2016.11.014. International Study Group on Pancreatic Surgery (ISGPS) PubMed DOI

Ducreux M., Cuhna A. S., Caramella C., et al. Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology. 2015;26(suppl 5):v56–v68. doi: 10.1093/annonc/mdv295. PubMed DOI

Delpero J. R., Bachellier P., Regenet N., et al. Pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: a French multicentre prospective evaluation of resection margins in 150 evaluable specimens. HPB: The Official Journal of the International Hepato Pancreato Biliary Association. 2014;16(1):20–33. doi: 10.1111/hpb.12061. PubMed DOI PMC

Bockhorn M., Uzunoglu F. G., Adham M., et al. Borderline resectable pancreatic cancer: a consensus statement by the International Study Group of Pancreatic Surgery (ISGPS) Surgery. 2014;155(6):977–988. doi: 10.1016/j.surg.2014.02.001. PubMed DOI

Mitchem J. B., Hamilton N., Gao F., Hawkins W. G., Linehan D. C., Strasberg S. M. Long-term results of resection of adenocarcinoma of the body and tail of the pancreas using radical antegrade modular pancreatosplenectomy procedure. Journal of the American College of Surgeons. 2012;214(1):46–52. doi: 10.1016/j.jamcollsurg.2011.10.008. PubMed DOI

Tol J. A., Gouma D. J., Bassi C., et al. Definition of a standard lymphadenectomy in surgery for pancreatic ductal adenocarcinoma: a consensus statement by the International Study Group on Pancreatic Surgery (ISGPS) Surgery. 2014;156(3):591–600. doi: 10.1016/j.surg.2014.06.016. PubMed DOI PMC

Ji Y. F., Huang H., Jiang F., Ni R. Z., Xiao M. B. S100 family signaling network and related proteins in pancreatic cancer (review) International Journal of Molecular Medicine. 2014;33(4):769–776. doi: 10.3892/ijmm.2014.1633. PubMed DOI

Moz S., Basso D., Padoan A., et al. Blood expression of matrix metalloproteinases 8 and 9 and of their inducers S100A8 and S100A9 supports diagnosis and prognosis of PDAC-associated diabetes mellitus. Clinica Chimica Acta. 2016;456:24–30. doi: 10.1016/j.cca.2016.02.018. PubMed DOI

Nilsen T., Sundström J., Lind L., Larsson A. Serum calprotectin levels in elderly males and females without bacterial or viral infections. Clinical Biochemistry. 2014;47(12):1065–1068. doi: 10.1016/j.clinbiochem.2014.01.003. PubMed DOI

Bartáková E., Štefan M., Stráníková A., et al. Calprotectin and calgranulin C serum levels in bacterial sepsis. Diagnostic Microbiology and Infectious Disease. 2019;93(3):219–226. doi: 10.1016/j.diagmicrobio.2018.10.006. PubMed DOI

Zhang L., Jiang H., Xu G., et al. Proteins S100A8 and S100A9 are potential biomarkers for renal cell carcinoma in the early stages: results from a proteomic study integrated with bioinformatics analysis. Molecular Medicine Reports. 2015;11(6):4093–4100. doi: 10.3892/mmr.2015.3321. PubMed DOI PMC

Nedjadi T., Evans A., Sheikh A., et al. S100A8 and S100A9 proteins form part of a paracrine feedback loop between pancreatic cancer cells and monocytes. BMC Cancer. 2018;18(1) doi: 10.1097/MPA.0b013e3182a6867e. PubMed DOI PMC

Gauss A., Sauer P., Stiehl A., et al. Evaluation of biliary calprotectin as a biomarker in primary sclerosing cholangitis. Medicine (Baltimore) 2016;95(17, article e3510) doi: 10.1097/MD.0000000000003510. PubMed DOI PMC

Wang S., Song R., Wang Z., Jing Z., Wang S., Ma J. S100A8/A9 in inflammation. Frontiers in Immunology. 2018;9:p. 1298. doi: 10.3389/fimmu.2018.01298. PubMed DOI PMC

Meijer B., Gearry R. B., Day A. S. The role of S100A12 as a systemic marker of inflammation. International Journal of Inflammation. 2012;2012:6. doi: 10.1155/2012/907078.907078 PubMed DOI PMC

Bagheri V. S100A12: friend or foe in pulmonary tuberculosis? Cytokine. 2017;92:80–82. doi: 10.1016/j.cyto.2017.01.009. PubMed DOI

Achouiti A., Föll D., Vogl T., et al. S100A12 and soluble receptor for advanced glycation end products levels during human severe sepsis. Shock. 2013;40(3):188–194. doi: 10.1097/SHK.0b013e31829fbc38. PubMed DOI

Kuipers M. T., Vogl T., Aslami H., et al. High levels of S100A8/A9 proteins aggravate ventilator-induced lung injury via TLR4 signaling. PLoS One. 2013;8(7, article e68694) doi: 10.1371/journal.pone.0068694. PubMed DOI PMC

Jonsson N., Nilsen T., Gille-Johnson P., et al. Calprotectin as an early biomarker of bacterial infections in critically ill patients: an exploratory cohort assessment. Critical Care and Resuscitation. 2017;19(3):205–213. PubMed

Fagerhol M. K., Nielsen H. G., Vetlesen A., Sandvik K., Lyberg T. Increase in plasma calprotectin during long-distance running. Scandinavian Journal of Clinical and Laboratory Investigation. 2005;65(3):211–220. doi: 10.1080/00365510510013587. PubMed DOI

Partelli S., Pecorelli N., Muffatti F., et al. Early postoperative prediction of clinically relevant pancreatic fistula after pancreaticoduodenectomy: usefulness of C-reactive protein. HPB: The Official Journal of the International Hepato Pancreato Biliary Association. 2017;19(7):580–586. doi: 10.1016/j.hpb.2017.03.001. PubMed DOI

Diabetes Mellitus in Pancreatic Cancer: A Distinct Approach to Older Subjects with New-Onset Diabetes Mellitus